History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

SIMPLE SUMMARY: Small cell lung cancer (SCLC) remains the most aggressive form of neuroendocrine tumor of the lung, for which treatment options remain limited. The introduction of immune checkpoint inhibitors has modified for the first time the therapeutic strategies in patients with extensive disea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Lazzari, Chiara, Mirabile, Aurora, Bulotta, Alessandra, Viganó, Maria Grazia, Ogliari, Francesca Rita, Ippati, Stefania, Dell’Oca, Italo, Santarpia, Mariacarmela, Lorusso, Vincenza, Reck, Martin, Gregorc, Vanesa
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957518/
https://ncbi.nlm.nih.gov/pubmed/33673630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13050998
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars